PDCD1 and melanoma: Here, we summarize five clinical studies for advanced melanoma performed at our clinical research center between 2015 and 2018, describing the clinical characteristics of patients with melanoma liver metastases treated with anti-PD-1 monoclonal antibody therapy, trying to explore possible prognostic factors.